ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
Conditions
- Recurrent Acute Lymphoblastic Leukemia
- Recurrent Acute Myeloid Leukemia
- Recurrent Myelodysplastic Syndrome
- Refractory Acute Lymphoblastic Leukemia
- Refractory Acute Myeloid Leukemia
- Refractory Myelodysplastic Syndrome
Interventions
- DRUG: Akt/ERK Inhibitor ONC201
- DRUG: Venetoclax
Sponsor
M.D. Anderson Cancer Center
Collaborators